Device Trial Radar · NCT04200937
IT Matters: The Erectile Restoration Registry
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
450
Planned (sponsor's estimate)
Start
Aug 5, 2021
Primary completion
Jan 2031
Study completion Dec 2031
Sponsor
- Lead sponsor
- Boston Scientific CorporationPublic (BSX)
- Sponsor type
- Industry
- First posted
- Dec 16, 2019
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- Male only, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objective of the It MATTERS registry is to collect Real-World Data (RWD) to monitor the safe and effective use of commercially available Boston Scientific Corporation (BSC) penile prostheses
Conditions
- Erectile Dysfunction
Interventions
Tactra MalleableDevice
The Tactra™ Penile Prosthesis is a sterile, single-use implant that is intended for use in the treatment of chronic, organic, erectile dysfunction (impotence) in adult males who are suitable candidates for implantation procedure.
Spectra™ Concealable Penile ProthesisDevice
The Spectra Penile Prothesis is a sterile, non-pyrogenic, single-use implant that is intended for use in the treatment of chronic, organic, erectile dysfunction (impotence) in men who are determined to be suitable candidates for implantation surgery.
AMS Ambicor™ Inflatable Penile ProsthesisDevice
The AMS Ambicor inflatable penile prothesis intended for use in the treatment of chronic, organic, male erectile dysfunction (impotence) in adult men who are determined to be suitable candidates for implantation surgery.
AMS 700™ Inflatable Penile Prosthesis w/Momentary Squeeze (MS) PumpDevice
The AMS 700 Inflatable Penile Prosthesis is intended for use in the treatment of chronic, organic, male erectile dysfunction (impotence).
AMS 700™ Inflatable Penile Prosthesis w/Tenacio™ PumpDevice
The AMS 700 Inflatable Penile Prosthesis is intended for use in the treatment of chronic, organic, male erectile dysfunction (impotence).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline to six months in the Erectile Function domain ofthe International Index of Erectile Function (IIEF-EF) questionnaire for TactraTime frame: Baseline to 6 months
Locations
25 sites in 3 countries. Site status is shown where the registry gives one.
USC Medical Center
Los Angeles, California
Ronald Reagan UCLA Medical Center
Los Angeles, California
Tower Urology-Research Facility
Los Angeles, California
22 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.